Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the ...

Intra-Cellular Therapies said on Tuesday its drug to prevent relapses in schizophrenia patients met the main goal of a late-stage trial.

For the past 70 years, schizophrenia treatments all targeted the same chemical: dopamine. While that works for some, it ...

Bristol Myers Squibb's (BMY) new schizophrenia drug, Cobenfy, improves symptoms with a well-tolerated safety profile in two ...

Some people who took a new schizophrenia drug for one year improved with only a few side effects, but many dropped out of the research Some people who took a new schizophrenia drug for a year ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...

A Promising Schizophrenia Drug Showed Mixed Results. What Does That Mean for Patients? Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many ...

Some people who took a new schizophrenia drug for a year improved with only a few side effects, but many dropped out of the research, the company announced Thursday. The results underscore the ...